• June 18, 2024

Hybrid duty relief may hurt petrol, diesel cars: Hyundai – Times of India

Hybrid duty relief may hurt petrol, diesel cars: Hyundai – Times of India
Share

NEW DELHI: Hyundai has joined local car companies – Tata Motors and Mahindra – in raising objections to any duty relaxations for hybrid vehicles, saying such a measure has the potential to disturb sales of petrol and diesel vehicles.
The demand for lower duty on hybrids is being raised by top Japanese companies such as Maruti Suzuki, Toyota and Honda, which argue that the technology helps reduce emissions while boosting fuel efficiency.
In the documents filed with Sebi for its maiden IPO, Hyundai said, “… with the objective to address climate issues, govt of India proposes to reduce GST on hybrid passenger vehicles to 5% and 12% on flex engines, while the GST on diesel and petrol vehicles is proposed to remain at 28%… In the event such amendment becomes effective, it could have an adverse impact on the sales volumes of our diesel and petrol vehicles which could affect our margins, business, and results of operations.”
Tata Motors and Mahindra have already been opposing any special benefits for hybrids. The two companies have said only electrics should get the special 5% GST rate, emphasising that only “zero emission vehicles” should get benefits and not those that offer only “fuel efficiency improvement technologies”.




Source


Share

Related post

Indian economy projected to grow 6.5-7% in FY 2024-25: Chief economic advisor Nageswaran – Times of India

Indian economy projected to grow 6.5-7% in FY…

Share Chief economic advisor V Anantha Nageswaran (Picture credit: PTI) Chief economic advisor V Anantha Nageswaran said on…
KRN Heat Exchanger IPO subscribed 58.14 times on second day – Times of India

KRN Heat Exchanger IPO subscribed 58.14 times on…

Share NEW DELHI: The initial public offering (IPO) of KRN Heat Exchanger and Refrigeration Ltd received a strong…
Piramal Pharma aims to double turnover to $2 billion by 2030 – Times of India

Piramal Pharma aims to double turnover to $2…

Share Piramal Pharma aims to double its turnover to $2 bn by 2030, driven by its “strategically- positioned’’…